On the other hand, long-term deletion of the SLC25A3 gene in the heart resulted in significant hypertrophy, with ventricular dilatation and reduced cardiac function, characteristics that are representative of the cardiomyopathy observed in humans with SLC25A3 mutations [151]. This evidence concerns the gene SLC25A3 and cardiac hypertrophy.